Geron’s Chief Commercial Officer Kapur to depart

Geron “announced that Anil Kapur, Executive Vice President, Corporate Strategy and Chief Commercial Officer, will depart the Company on August 31, 2024, to pursue other interests. A search for a new Chief Commercial Officer is already underway, and in the interim, Andrew Grethlein, Ph.D., Executive Vice President, Chief Operating Officer, will serve as leader of the commercial organization. Geron Board of Directors member Dawn Carter Bir, who has led numerous successful new product launches, including as Chief Commercial Officer of Reata Pharmaceuticals and as Vice President, Sales at Pharmacyclics, will support Dr. Grethlein in this interim role with additional oversight of the commercial business.”